ArcticZymes Technologies launches IsoPol BST+ 10X Reaction Buffer Pack and new application page for Isothermal Amplification

Tromsø, Norway, 08 July, 2020: Currently there is a large demand for rapid and reliable point-of-care (POC) diagnostic tests for viral and bacterial pathogens to expedite clinical decision making and control disease spread. When establishing these new POC assays, the use of robust components allowing amplification directly from biological sample material is essential. Our new optimized IsoPol BST+ 10X Reaction …

ArcticZymes has entered into an agreement with ReiThera to supply its SAN product for ReiThera’s COVID-19 vaccine candidate

Tromsø, 02 July, 2020:  ArcticZymes AS (OSE:AZT), a subsidiary of ArcticZymes Technologies ASA, announces that it has entered into a supply agreement with vaccine specialist ReiThera Srl (Rome, Italy) for the supply of Salt Active Nuclease (SAN-HQ) to be used in the development and manufacturing of ReiThera’s novel vaccine candidate against COVID-19. The vaccine candidate, which is based on ReiThera’s …